Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT04693663

Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Eye Hospital Pristina Kosovo · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess visual and refractive outcomes after laser vision correction (LVC) - ReLex Smile to correct residual myopic refraction after 6 months of pseudophakic (IOL) implantation. Before SMILE YAG-Laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, in pseudophakic patients with residual refraction. When the YAG Laser is applied after the SMILE, there will be a diopter change.

Detailed description

The residual myopic refraction after 6 month on pseudophakic patients using Relex-Smile surgery using VisuMax Femtosecond Laser.The residual myopic refractive power is between -0.75D till -5.50D.The optical zone(lenticule diameter) and cap diameter were 6.5 and 7.5 mm respectively.After dissection of both anterior and posterior planes, the lenticule was extracted through 120 degree superior 3.5mm incision and marked with a sterile marker(Viscot-Medster)

Conditions

Interventions

TypeNameDescription
PROCEDURERelex-Smile surgerysurgery using Relex-Smile

Timeline

Start date
2017-06-01
Primary completion
2018-06-01
Completion
2026-06-01
First posted
2021-01-05
Last updated
2024-08-27

Locations

1 site across 1 country: Kosovo

Source: ClinicalTrials.gov record NCT04693663. Inclusion in this directory is not an endorsement.

Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile (NCT04693663) · Clinical Trials Directory